Repurposing some of the Well-known Non-steroid Anti-inflammatory Drugs (NSAIDs) for Cancer Treatment

SM Sousa, CPR Xavier… - Current Topics in …, 2023 - ingentaconnect.com
Drug repurposing is a strategy used to develop new treatments based on approved or
investigational drugs outside the scope of their original clinical indication. Since this …

Unveiling the intricate supramolecular chemistry of γ-cyclodextrin-epigallocatechin gallate inclusion complexes

P Kumar, VK Bhardwaj, R Purohit - Industrial & Engineering …, 2024 - ACS Publications
Green tea's main polyphenol, epigallocatechin-gallate (EgCg), garners attention for diverse
health-promoting properties. Due to the limited bioavailability of EgCg, drug formulation …

[HTML][HTML] Co-delivery of photosensitizer and diclofenac through sequentially responsive bilirubin nanocarriers for combating hypoxic tumors

Y Zhou, F Tong, W Gu, S He, X Yang, J Li… - … Pharmaceutica Sinica B, 2022 - Elsevier
Considering that photodynamic therapy (PDT)-induced oxygen consumption and
microvascular damage could exacerbate hypoxia to drive more glycolysis and …

Targeting metabolism by B-raf inhibitors and diclofenac restrains the viability of BRAF-mutated thyroid carcinomas with Hif-1α-mediated glycolytic phenotype

M Aprile, S Cataldi, C Perfetto, A Federico… - British Journal of …, 2023 - nature.com
Background B-raf inhibitors (BRAFi) are effective for BRAF-mutated papillary (PTC) and
anaplastic (ATC) thyroid carcinomas, although acquired resistance impairs tumour cells' …

[HTML][HTML] Selective modification of diclofenac to reduce the adverse effects; A computer-aided drug design approach

MK Hasan, S Akhter, K Fatema, MR Hossain… - Informatics in Medicine …, 2023 - Elsevier
Diclofenac (DCF) is a non-steroidal anti-inflammatory drug (NSAID), commonly used for the
treatment of pain. It can inhibit prostaglandin synthesis by blocking cyclooxygenase (COX). It …

Mebendazole targets essential proteins in glucose metabolism leading gastric cancer cells to death

EL da Silva, FP Mesquita, DR Aragão… - Toxicology and Applied …, 2023 - Elsevier
Gastric cancer (GC) is among the most-diagnosed and deadly malignancies worldwide.
Deregulation in cellular bioenergetics is a hallmark of cancer. Based on the importance of …

Diclofenac embedded in silk fibroin fibers as a drug delivery system

A Opálková Šišková, E Kozma, A Opálek, Z Kroneková… - Materials, 2020 - mdpi.com
Silk fibroin is a biocompatible, non-toxic, mechanically robust protein, and it is commonly
used and studied as a material for biomedical applications. Silk fibroin also gained particular …

[HTML][HTML] Engineering nanoliposomes to enhance cancer immunotherapy by reversing immunosuppression and synergistically boosting tumour immunogenicity

C Zhang, Y Tan, J Huang, X Tang, H Xiang, B Shen… - Materials & Design, 2023 - Elsevier
The clinical success of immune checkpoint inhibitors (ICIs) has initiated a new era in the
treatment of metastatic cancer. Unfortunately, the overall response rate of ICIs in pretreated …

Human Cytochrome P450 2C9 and its polymorphic modifications: Electroanalysis, catalytic properties, and approaches to the regulation of enzymatic activity

VV Shumyantseva, TV Bulko, PI Koroleva, EV Shikh… - Processes, 2022 - mdpi.com
The electrochemical properties of cytochrome P450 2C9 (CYP2C9) and polymorphic
modifications P450 2C9* 2 (CYP2C9* 2) and P450 2C9* 3 (CYP2C9* 3) were studied. To …

Molecular docking: Bioactive compounds of Mimosa pudica as an inhibitor of Candida albicans Sap 3

GM Gholam, IA Firdausy, IM Artika, RM Abdillah… - bioRxiv, 2022 - biorxiv.org
Candida albicans (C. albicans) is a commensal microbiota that resides in humans. However,
in certain cases, C. albicans can infect and cause several diseases to humans. This study …